SHFH Scientist Home Future Health Ltd
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 2032609 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-265.8%
TTM EPS YoY-402.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin42.3%
Operating margin-60.2%
Net margin-60.2%
FCF margin—
EBITDA margin-58.0%
Returns
ROE-364.9%
ROA-51.8%
ROIC (approx.)—
Asset turnover0.86x
Leverage & solvency
Liabilities / assets112.9%
Debt / equity—
Current ratio0.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.78x
Accruals ratio-11.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2025Q1*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $211,984 | $82,878 | $188,756 | $88,075 | $39,604 | $31,552 | $44,824 | — |
| Cost of revenue | $90,964 | $55,194 | $129,688 | $55,486 | $23,534 | $18,013 | $25,135 | — |
| Gross profit | $121,020 | $29,109 | $59,068 | $32,589 | $16,070 | $13,539 | $19,689 | — |
| SG&A expense | $112,808 | $126,961 | $161,140 | $185,315 | $63,915 | $51,687 | $12,695 | — |
| Operating income | $8,212 | -$97,852 | -$102,072 | -$152,726 | -$47,845 | -$38,148 | $6,994 | — |
| Pretax income | $8,212 | -$97,852 | -$102,072 | -$152,726 | -$47,845 | -$38,148 | $6,994 | — |
| Income tax | $0 | $0 | $0 | $0 | $0 | -$935 | $935 | — |
| Net income | $8,212 | -$97,852 | -$102,072 | -$152,726 | -$47,845 | -$37,213 | $6,059 | -$15,155 |
| EBITDA | $11,929 | -$94,132 | -$98,342 | -$151,012 | -$47,845 | -$38,148 | $6,994 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 23.72M | 23.72M | 23.72M | — | 23.66M | 23.50M | 23.48M | — |
| Banking | ||||||||
| Deposits | $50,396 | — | — | $48,417 | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $13,653 | $9,047 | $15,332 | $68,888 | $275,610 | $111,386 | $16,135 | $18,621 |
| Inventory | $129,162 | $33,898 | $31,376 | $34,006 | $1,991 | $3,329 | $3,460 | $2,627 |
| Current assets | $226,075 | $125,324 | $131,904 | $192,246 | $325,732 | $114,715 | $19,595 | $21,248 |
| PP&E, net | $61,440 | $65,194 | $68,928 | $73,175 | — | $0 | — | $0 |
| Total assets | $607,898 | $529,844 | $558,759 | $644,365 | $723,008 | $114,715 | $19,595 | $21,248 |
| Current liabilities | $424,121 | $340,299 | $252,124 | $214,458 | $123,388 | $63,182 | $19,568 | $27,268 |
| Total liabilities | $686,103 | $616,168 | $547,332 | $530,974 | $456,004 | $63,182 | $19,568 | $27,268 |
| Shareholders' equity | -$78,205 | -$86,324 | $11,427 | $113,391 | $267,004 | $51,533 | $27 | -$6,020 |
| Shares outstanding | 23.72M | 23.72M | 23.72M | 23.72M | 23.72M | 23.54M | 23.48M | 23.48M |
| Cash flow statement | ||||||||
| Operating cash flow | -$44,577 | -$12,845 | -$71,811 | -$138,804 | -$99,348 | -$5,294 | -$4,832 | $8,681 |
| Financing cash flow | $49,229 | $6,595 | $18,510 | $7,697 | $265,484 | $100,613 | $2,346 | -$9,021 |
| Depreciation & amortization | $3,717 | $3,720 | $3,730 | $1,714 | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 9 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.